Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q1 2024 · 10-Q
Revenue$51.51M$51.51M+13.8% vs Q1 2023 Net Income-$4.23M-$4.23MN/M vs Q1 2023 EPS Diluted-$0.06-$0.06N/M vs Q1 2023 Operating Income-$9,868,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Free Cash Flowderived-$16,367,000N/M Margins · derivedOperating margin-19.2%+9.2 pt vs Q1 2023
Net margin-8.2%+14.3 pt vs Q1 2023
ended Mar 31, 2024 · filed May 7, 2024 · 37 d after period end